ResMed Performance

RMD -- USA Stock  

USD 105.03  1.63  1.53%

Macroaxis gives ResMed performance score of 0 on a scale of 0 to 100. The organization holds Beta of -0.0268 which implies as returns on market increase, returns on owning ResMed are expected to decrease at a much smaller rate. During bear market, ResMed is likely to outperform the market.. Even though it is essential to pay attention to ResMed current trending patterns, it is always good to be careful when utilizing equity existing price patterns. Macroaxis philosophy towards forecasting future performance of any stock is to check both, its past performance charts as well as the business as a whole, including all available technical indicators. ResMed exposes twenty-one different technical indicators which can help you to evaluate its performance. ResMed has expected return of -0.3086%. Please be advised to check ResMed Information Ratio, Value At Risk as well as the relationship between Value At Risk and Expected Short fall to decide if ResMed past performance will be repeated at some point in the near future.
Horizon     30 Days    Login   to change

ResMed Relative Risk vs. Return Landscape

If you would invest  11,343  in ResMed on September 18, 2018 and sell it today you would lose (840.00)  from holding ResMed or give up 7.41% of portfolio value over 30 days. ResMed is generating negative expected returns assuming volatility of 1.5455% on return distribution over 30 days investment horizon. In other words, 14% of equities are less volatile than the company and above 99% of equities are expected to generate higher returns over the next 30 days.
 Daily Expected Return (%) 
      Risk (%) 
Considering 30-days investment horizon, ResMed is expected to under-perform the market. In addition to that, the company is 1.48 times more volatile than its market benchmark. It trades about -0.2 of its total potential returns per unit of risk. The DOW is currently generating roughly -0.08 per unit of volatility.

ResMed Market Risk Analysis

Sharpe Ratio = -0.1997
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small Returns
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative ReturnsRMD

ResMed Relative Performance Indicators

Estimated Market Risk
 1.55
  actual daily
 
 86 %
of total potential
  
Expected Return
 -0.31
  actual daily
 
 1 %
of total potential
  
Risk-Adjusted Return
 -0.2
  actual daily
 
 1 %
of total potential
  
Based on monthly moving average ResMed is performing at about 0% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ResMed by adding it to a well-diversified portfolio.

ResMed Performance Rating

ResMed Risk Adjusted Performance Analysis

0 

Risk-Adjusted Performance

Over the last 30 days ResMed has generated negative risk-adjusted returns adding no value to investors with long positions.

ResMed Alerts

Equity Alerts and Improvement Suggestions

ResMed generates negative expected return over the last 30 days
About 67.0% of the company shares are owned by institutional investors
Latest headline from MacroaxisInsider: Exercise or conversion by Rich Sulpizio of 36000 shares of ResMed subject to Rule 16b-3

ResMed Performance Indicators

ResMed Basic Price Performance Measures

Quick Ratio1.32
Fifty Two Week Low75.62
Target High Price125.00
Payout Ratio63.93%
Fifty Two Week High116.64
Target Low Price75.00
Trailing Annual Dividend Yield1.23%

ResMed Dividends

ResMed Dividends Analysis

Check ResMed dividend payout schedule and payment analysis over time. Analyze past dividends calendar and estimate annual dividend income
Check Dividends  
Additionally take a look at Your Equity Center. Please also try ETF Directory module to find actively-traded exchange traded funds (etf) from around the world.
Search macroaxis.com